Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation followingpartial gastrectomy
Av. Safatle-ribeiro et al., Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation followingpartial gastrectomy, DIG DIS SCI, 44(2), 1999, pp. 243-252
Helicobacter pylori and partial gastric resection are risk factors for gast
ric cancer. Our aims were to investigate the presence of H. pylori in postg
astrectomy patients and to correlate that with alterations in mucosal archi
tecture and cell proliferation. One hundred fifty-one endoscopic biopsies f
rom 22 patients, (15-47 years of age, mean 29.2 years) following partial ga
strectomy with Billroth II reconstruction for peptic ulcer disease, were ex
amined for the presence of H. pylori using Giemsa staining. Sections were s
cored for grade of hyperplasia, intestinal metaplasia, dysplasia, inflammat
ion, and atrophy. Immunohistochemistry for proliferative cell nuclear antig
en (PCNA) was used to characterize cell proliferation. H. pylori was observ
ed in 17/22 (77.3%) of patients or in 57/151 (37.7%) of biopsies. Metaplasi
a was seen in 18/22, chronic atrophic gastritis in 20/22, and cystic glandu
lar dilation in 21/22 patients. The highest type of metaplasia in each pati
ent was: four Type I, five Type IIA and nine Type IIB. Dysplasia was presen
t in 16 biopsies from nine patients. H. pylori was more prevalent in intest
inal metaplasia type I (44.8% of biopsies), than in type IIA (32.7%) or typ
e IIB (25%). No H. pylori was detected in regions showing dysplasia or cyst
ic glandular dilation. H. pylori colonization was associated with degree of
inflammation (P = 0.00001) and cell proliferation (P = 0.0001). In conclus
ion, H. pylori is commonly seen many years after gastrectomy, it is associa
ted with an increased epithelial cell proliferation, and it is not present
in areas of histologic markers of premalignancy (type IIB metaplasia and dy
splasia).